Saturday 17 October 2026
Export ONMD’s income statement to Excel — free account
OneMedNet Corporation
ONMD Healthcare Health Information Services
OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024. In the quarter to June 2026, revenue grew 88.4%, EPS fell 148.2%, free cash flow grew 14.1% and total debt rose 75.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.51
0.24
−5.05%
Follow ONMD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Altman Z-Score |
(77.91) | (50.35) | (357.02) | (104.52) | — | — | — | — |
P/S ratio |
36.06 | 59.39 | 5.28 | 0.00 | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(197.32) | (134.49) | (933.19) | (317.91) | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
P/Operating CF |
(28.61) | (19.13) | (3.12) | (10.62) | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
EV/Sales |
35.97 | 63.06 | 9.07 | 0.00 | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
EV/Operating CF |
(6.52) | (5.83) | (1.93) | (9.08) | — | — | — | — |
EV/FCF |
(6.50) | (5.79) | (1.89) | (9.08) | — | — | — | — |
Quick Ratio |
0.33 | 0.17 | 0.01 | 0.01 | 0.02 | 1.56 | 1.56 | — |
Current Ratio |
0.43 | 0.19 | 0.03 | 0.02 | 0.02 | 1.85 | 1.85 | — |
Net Debt/EBITDA |
0.01 | (0.06) | (0.50) | (0.16) | 0.01 | 0.77 | 0.77 | — |
Debt/Assets |
45.28% | 96.81% | 745.04% | 116.37% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.33) | (0.23) | (0.26) | (0.06) | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.46 | 0.31 | 1.16 | 0.02 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
2.68 | 0.69 | 0.14 | 0.15 | (2.79) | (0.07) | (0.07) | — |
Capex/Depreciation |
(0.20) | (0.89) | (1.57) | (2.32) | — | — | — | — |
Interest Coverage |
(144.28) | (65.34) | (623.00) | (19.13) | — | — | (616.21) | — |
| 29.62% | 68.92% | 117.61% | 115.76% | 0.00% | 10.26% | 10.26% | — | |
| (95.30%) | (483.37%) | (3,853.96%) | (51.12%) | 0.00% | 4.36% | 8.72% | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
104.75% | 65.34% | 252.58% | 118.81% | (17.31%) | 2,086.03% | 2,086.03% | — |
Average Days of Receivables |
132.95 | 120.91 | 54.34 | 6.01 | — | — | — | — |
Research and Development Expense of Revenue |
111.48% | 228.15% | 202.25% | 137.99% | — | — | — | — |
Selling, General and Administrative Expense of Revenue |
562.84% | 1,221.93% | 456.32% | 499.91% | 0.00% | — | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
149.52% | 97.67% | 144.47% | 161.75% | — | — | — | — |
Graham Net Nets |
(0.06) | (0.42) | (2.51) | (0.66) | — | — | — | — |
Graham Number |
3.07 | 19.66 | 139.01 | 444.51 | — | — | — | — |
Earnings Yield |
(5.72%) | (22.24%) | (626.97%) | (75.97%) | — | — | — | — |
Free Cash Flow Yield |
(15.34%) | (18.34%) | (90.82%) | (11.34%) | — | — | — | — |
Revenue per Share |
0.31 | 0.23 | 1.40 | 2.90 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(1.68) | (2.48) | (6.59) | (11.83) | (0.08) | (1.15) | (0.03) | — |
Capex per Share |
0.00 | (0.02) | (0.06) | (0.15) | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(1.69) | (2.49) | (6.65) | (11.98) | (0.08) | (1.15) | (0.03) | — |
Cash per Share |
0.24 | 1.08 | 0.06 | 0.68 | 0.00 | 1.38 | 0.03 | — |
Shareholders Equity per Share |
(0.67) | (5.68) | (18.49) | (66.33) | 1.64 | (26.12) | 7.27 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(0.67) | (5.68) | (18.49) | (66.33) | 1.64 | (26.12) | 7.27 | — |
Free Cash Flow |
(7.52) | (7.00) | (4.83) | (4.76) | (0.94) | (0.38) | (0.38) | — |
Working Capital |
(2.73) | (15.61) | (13.47) | (25.71) | (1.95) | 0.25 | 0.25 | — |
Capital Expenditures |
(0.01) | (0.05) | (0.04) | (0.06) | — | — | — | — |
Net Current Asset Value |
(3.02) | (16.06) | (13.54) | (27.26) | (9.09) | (125.93) | (8.63) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Capex to Sales |
0.01 | 0.08 | 0.04 | 0.05 | — | — | — | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
1.16 | 0.53 | 0.28 | 0.30 | — | — | — | — |
Cash ROIC |
835.11% | 75.13% | 48.65% | 19.36% | (4.71%) | 4.64% | (0.35%) | — |
Accounts Receivable Turnover |
3.84 | 3.52 | 11.94 | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.39 | 0.17 | 0.39 | 0.00 | — | — | — | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Average Days of Payables |
685.31 | 2,385.14 | 1,486.03 | 283.94 | — | — | — | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — |
Average Receivables |
0.35 | 0.18 | 0.09 | — | — | — | — | — |
Average Payables |
4.77 | 5.36 | 2.93 | — | — | — | — | — |
Average Assets |
2.94 | 2.10 | 0.88 | 59.57 | 73.46 | 117.86 | 58.93 | — |
Average Common Equity |
(9.46) | (14.70) | (28.72) | (26.31) | 5.67 | 50.04 | 50.04 | — |
Columns are period end dates · fundamentals updated 2 Oct 2026